Unknown

Dataset Information

0

Genetic Variants in the Regulatory T cell-Related Pathway and Colorectal Cancer Prognosis.


ABSTRACT:

Background

High numbers of lymphocytes in tumor tissue, including T regulatory cells (Treg), have been associated with better colorectal cancer survival. Tregs, a subset of CD4+ T lymphocytes, are mediators of immunosuppression in cancer, and therefore variants in genes related to Treg differentiation and function could be associated with colorectal cancer prognosis.

Methods

In a prospective German cohort of 3,593 colorectal cancer patients, we assessed the association of 771 single-nucleotide polymorphisms (SNP) in 58 Treg-related genes with overall and colorectal cancer-specific survival using Cox regression models. Effect modification by microsatellite instability (MSI) status was also investigated because tumors with MSI show greater lymphocytic infiltration and have been associated with better prognosis. Replication of significant results was attempted in 2,047 colorectal cancer patients of the International Survival Analysis in Colorectal Cancer Consortium (ISACC).

Results

A significant association of the TGFBR3 SNP rs7524066 with more favorable colorectal cancer-specific survival [hazard ratio (HR) per minor allele: 0.83; 95% confidence interval (CI), 0.74-0.94; P value: 0.0033] was replicated in ISACC (HR: 0.82; 95% CI, 0.68-0.98; P value: 0.03). Suggestive evidence for association was found with two IL7 SNPs, rs16906568 and rs7845577. Thirteen SNPs with differential associations with overall survival according to MSI in the discovery analysis were not confirmed.

Conclusions

Common genetic variation in the Treg pathway implicating genes such as TGFBR3 and IL7 was shown to be associated with prognosis of colorectal cancer patients.

Impact

The implicated genes warrant further investigation.

SUBMITTER: Neumeyer S 

PROVIDER: S-EPMC7976673 | biostudies-literature | 2020 Dec

REPOSITORIES: biostudies-literature

altmetric image

Publications

Genetic Variants in the Regulatory T cell-Related Pathway and Colorectal Cancer Prognosis.

Neumeyer Sonja S   Hua Xinwei X   Seibold Petra P   Jansen Lina L   Benner Axel A   Burwinkel Barbara B   Halama Niels N   Berndt Sonja I SI   Phipps Amanda I AI   Sakoda Lori C LC   Schoen Robert E RE   Slattery Martha L ML   Chan Andrew T AT   Gala Manish M   Joshi Amit D AD   Ogino Shuji S   Song Mingyang M   Herpel Esther E   Bläker Hendrik H   Kloor Matthias M   Scherer Dominique D   Ulrich Alexis A   Ulrich Cornelia M CM   Win Aung K AK   Figueiredo Jane C JC   Hopper John L JL   Macrae Finlay F   Milne Roger L RL   Giles Graham G GG   Buchanan Daniel D DD   Peters Ulrike U   Hoffmeister Michael M   Brenner Hermann H   Brenner Hermann H   Newcomb Polly A PA   Chang-Claude Jenny J  

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 20201002 12


<h4>Background</h4>High numbers of lymphocytes in tumor tissue, including T regulatory cells (Treg), have been associated with better colorectal cancer survival. Tregs, a subset of CD4<sup>+</sup> T lymphocytes, are mediators of immunosuppression in cancer, and therefore variants in genes related to Treg differentiation and function could be associated with colorectal cancer prognosis.<h4>Methods</h4>In a prospective German cohort of 3,593 colorectal cancer patients, we assessed the association  ...[more]

Similar Datasets

| S-EPMC3721524 | biostudies-literature
| S-EPMC9389459 | biostudies-literature
| S-EPMC10854446 | biostudies-literature
| S-EPMC10529222 | biostudies-literature
| S-EPMC6601596 | biostudies-literature
| S-EPMC10876254 | biostudies-literature
| S-EPMC4794727 | biostudies-literature
| S-EPMC3566082 | biostudies-literature
| S-EPMC6767781 | biostudies-literature
| S-EPMC4779688 | biostudies-literature